scispace - formally typeset
Open AccessJournal ArticleDOI

Ferritin nanocages: A biological platform for drug delivery, imaging and theranostics in cancer.

Reads0
Chats0
TLDR
The structure and functions of ferritin nanocages are described, and an overview about the nanotechnological approaches implemented for applying them to cancer diagnosis and treatment is provided.
About
This article is published in Pharmacological Research.The article was published on 2016-05-01 and is currently open access. It has received 183 citations till now. The article focuses on the topics: Nanocages & Targeted drug delivery.

read more

Citations
More filters
Journal ArticleDOI

Size-Dependent Ag2S Nanodots for Second Near-Infrared Fluorescence/Photoacoustics Imaging and Simultaneous Photothermal Therapy

TL;DR: Size-dependent Ag2S nanodots with well-defined nanostructure with ideal resistance to photobleaching, effective cellular uptake, preferable tumor accumulation, and in vivo elimination are reported, facilitating NIR-II fluorescence/photoacoustics imaging with both ultrasensitivity and microscopic spatial resolution and simultaneous photothermal tumor ablation.
Journal ArticleDOI

Iron as a Central Player and Promising Target in Cancer Progression.

TL;DR: Since iron adds to shaping major hallmarks of cancer, innovative therapeutic strategies to address the iron pool of tumor cells or cells of the tumor microenvironment for the treatment of cancer are emphasized.
Journal ArticleDOI

Protein-based nanoparticles in cancer vaccine development.

TL;DR: Different classes of virus-like particles and caged protein nanoparticles that have been used as vehicles to transport and increase the interaction of cancer vaccine components with the immune system are discussed.
Journal ArticleDOI

Mito-Bomb: Targeting Mitochondria for Cancer Therapy.

TL;DR: In this paper, the rational design, functionalization, and applications of diverse mitochondria-targeting units, involving organic phosphine/sulfur salts, quaternary ammonium (QA) salts, peptides, transition-metal complexes, guanidinium or bisguaninium, as well as mitochondriatargeting cancer therapies including PDT, PTT, CDT, and others are summarized.
References
More filters
Journal ArticleDOI

Nanocarriers as an emerging platform for cancer therapy

TL;DR: The arsenal of nanocarriers and molecules available for selective tumour targeting, and the challenges in cancer treatment are detailed and emphasized.
Journal ArticleDOI

Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes

TL;DR: It is shown that exosomes—endogenous nano-vesicles that transport RNAs and proteins—can deliver short interfering (si)RNA to the brain in mice, and the therapeutic potential of exosome-mediated siRNA delivery was demonstrated by the strong mRNA and protein knockdown of BACE1, a therapeutic target in Alzheimer's disease, in wild-type mice.
Journal ArticleDOI

Drug delivery and nanoparticles:applications and hazards

TL;DR: An overview on some of the currently used systems for drug delivery, varying from biological substances like albumin, gelatine and phospholipids for liposomes, and more substances of a chemical nature like various polymers and solid metal containing nanoparticles is provided.
Journal ArticleDOI

Exosomes: Current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials

TL;DR: Strategies for exosome isolation, the understanding to date of exosomes composition, functions, and pathways, and their potential for diagnostic and therapeutic applications are summarized.
Book

Biochemistry of lipids, lipoproteins, and membranes

TL;DR: This chapter discusses the physical properties and functional Roles of Lipids in Membranes, as well as the Dynamics of Lipoprotein Transport in the Circulatory System.
Related Papers (5)
Frequently Asked Questions (19)
Q1. What are the contributions in "Ferritin nanocages: a biological platform for drug delivery, imaging and theranostics in cancer" ?

In this paper, the authors proposed to use a protein-based nanocage for early detection of cancer onset and the generation of smart drug delivery systems for targeted chemotherapy release in cancer cells. 

the combination of imaging and therapeuticfunctionality into ferritin nanocages seems to be the most promising and fascinating frontier in cancer theranostics. 

The plasticity of ferritin as a mineralization chamber for heavy atoms or complexes, and the possibility of modifying ferritin nanocages by protein engineering or by chemical reaction to insert probe molecules, are features that make ferritin an ideal device for imaging [53]. 

Their high stability, biocompatibility, ability to disassemble and reassemble in a shape memory fashion and disposition for surface modification make ferritin nanoparticles an ideal platform for drug delivery [55]. 

Since it has a uniform cage, ferritin allows the precise control of the amount of encapsulated molecules, which is a critical feature in defining drug dosage. 

Ferritin-based nanocages could be implemented for the delivery of radioisotopes increasing loading efficiency and improving pharmacokinetics. 

Combining optical and nanotargeted strategies could improve and refine intraoperative imaging, to properly excise a tumor lesion with adequate margins, and provide targeted diagnostic tools for cancer follow up. 

Doxorubicin (DOX) encapsulation in ferritin nanocages represents the most extensively investigated system for delivery of anticancer drugs [47]. 

Injection of such nanoparticles in MDA-231 tumor-bearing mice caused a drop of the T2 signal due to TfR1-dependent tumor accumulation [78]. 

Five nm Gd nanoparticles have been produced inside ferritins, obtaining nanoparticles with longitudinal and transverse relaxivity from 10 to 70 times higher than commercially available Gd-chelates [81]. 

Ferritin nanocages have been extensively exploited for the biomineralization of metal oxides, such as iron [57], manganese [58], cobalt [59], chromium and nickel oxides [60]. 

Hainfeld has developed ferritin cages with a payload of about 800 235 U atoms/nanoparticle, able to kill surrounding tumor cells [75]. 

While ferritin nanoparticles have been widely investigated in the context of nanotechnology, their main application concerns the field of nanomedicine. 

most of the currently used chemotherapies are not based on metals such as cisplatin, and the incorporation of non-metal-containing drugs within ferritin is complicated by their limited interaction with the protein cage. 

Aime et al. exploited a pH-mediated ferritin disassembly to load about 8-10 GdHPDO3A/nanoparticle, obtaining a r1 relaxivity of 80 mM -1 s -1 [83]. 

These short noncoding RNA molecules, have been strongly related to either cancer progression or resistance, suggesting that miRNA/siRNA-based therapy could be associated with standard treatment. 

Cisplatin encapsulation was first reported in 2007 by Gao and coworkers [68], who also studied the cellular uptake of these nanoparticles and several applications in tumor treatment [69]. 

In vivo results clearly demonstrated that ferritin nanocages improve DOX bioavailability, tumor accumulation and clearance, and suggested that ferritin-mediated active targeting provides a major contribution (Figure 4) [73]. 

At present, unfunctionalized DOX-loaded ferritin represents the most extensively investigated of the ferritin-based nanoparticles, and several in vitro and in vivo studies have demonstrated it to be successful.